Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Organigram Global Inc. (OGI)

BGM Group Ltd. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. and Organigram Global Inc. are of similar size ($131.1M and $125.7M). Organigram Global Inc. trades at the lower P/E: 2.0× against 148×. Organigram Global Inc. has the higher net margin (28.4% vs 1.96%) and the lower return on invested capital (−1.53% vs 0.00%). Across the 16 metrics below, Organigram Global Inc. leads on 10 and BGM Group Ltd. on 6.

Valuation

Metric BGM OGI Drug Manufacturers Specialty & Generic median
P/E 148.17 2.02 20.55
P/S n/m 0.57 2.08
P/B n/m 0.36 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 14.45 12.22
EV/Sales (0.09) 0.60 2.87
Earnings yield 0.67% 49.46% (15.94%)
Free cash flow yield 0.00% (16.64%) 0.00%

Profitability

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 36.47% 53.51%
Operating margin 0.00% (3.91%) 0.00%
Net margin 1.96% 28.44% (2.45%)
Free cash flow margin 0.00% (9.46%) 0.00%
Return on equity 0.00% 20.20% (0.80%)
Return on assets 0.00% 12.70% (1.67%)
Return on invested capital 0.00% (1.53%) 0.00%

Growth

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 39.51% 5.22%
EPS growth (last fiscal year) 10.00% 60.00% 42.91%
Revenue growth, 5-year CAGR (5.39%) 24.30% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.04 0.04
Current ratio 1.25 2.61 2.41
Net debt to EBITDA 0.97 (31.56) 1.01

Dividend

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric BGM OGI Drug Manufacturers Specialty & Generic median
Market cap 125.72m 131.11m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack